Pharmaceutical Artificial Intelligence in 2020: The Sector is Heating Up For Investments
Table of Contents: Introduction The abundance of venture capital, major funding rounds New AI-driven biotech startups founded in 2020 Notable …
Industry Trends
FDA Analysis of Antibiotic Development - with Hubris!
(This post originally appeared on David Shlaes's personal blog) The US FDA just published an analysis of antibiotic development looking back …
The Increasing Potential of Virtual Reality in Drug Design
Using virtual reality (VR) for manipulating 3D models of molecules in the context of drug design is an emerging technological …
![[Interview] Building Canada’s Life Sciences Community …](/files/blog/20200511_094209.6305_adMare_BioInnovations_1.jpg)
[Interview] Building Canada’s Life Sciences Community and Thinking Global
Canada has a firm place in the global life sciences ecosystem, being the tenth largest market for pharmaceutical sales, and …
![[Interview] Shaping European Life Sciences with …](/files/blog/20200501_150827.1365_loubna-okra.jpg)
[Interview] Shaping European Life Sciences with AI
There is a great deal of hype and a lot of misconceptions among life science experts as to how AI …
Microbiome: Can Human Microbes Become A Panacea?
The microbiome is implicated in a number of metabolic pathways and communicates closely with our body in health and diseases. …
Top Companies At The Forefront Of RNA Therapeutics Development
Alongside the topic of gene editing technologies that keeps making headlines these days, there is also a wave of breakthroughs …
Paving A Pathway To Pharma 4.0
Pharmaceutical manufacturers find themselves at a critical juncture. In the past 30 years, pharma has seen some significant shifts. Consider …
A Race For Better Gene Editing Tech Is On
A transformative technology for gene editing - clustered regularly interspaced short palindromic repeats (CRISPR) -- has become ubiquitous, at least …
AI For Commercial Life Sciences: 3 Trends You Can’t Ignore In 2020
As we enter a new decade, our belief in the the impact of Artificial intelligence (AI) is only getting stronger. …
The Promise Of Cell Technologies In Immunotherapy
The number of immunotherapies in clinical trial rolls over 5000 now, and immunology has become a common approach in some …
The Evolution Of Pharmaceutical R&D Model
There is a plethora of analytics reports, including ones by Deloitte, DKV Global, and Ernst and Young, all pointing out …
